90 related articles for article (PubMed ID: 26797521)
1. The M358R variant of α(1)-proteinase inhibitor inhibits coagulation factor VIIa.
Sheffield WP; Bhakta V
Biochem Biophys Res Commun; 2016 Feb; 470(3):710-713. PubMed ID: 26797521
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor.
Gierczak RF; Pepler L; Bhagirath V; Liaw PC; Sheffield WP
Thromb Res; 2014 Nov; 134(5):1142-9. PubMed ID: 25242242
[TBL] [Abstract][Full Text] [Related]
3. Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition.
Roddick LA; Bhakta V; Sheffield WP
BMC Biochem; 2013 Nov; 14():31. PubMed ID: 24215622
[TBL] [Abstract][Full Text] [Related]
4. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
Sutherland JS; Bhakta V; Filion ML; Sheffield WP
Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
[TBL] [Abstract][Full Text] [Related]
5. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity.
Gierczak RF; Bhakta V; Xie M; Sheffield WP
J Biotechnol; 2015 Aug; 208():54-62. PubMed ID: 26043905
[TBL] [Abstract][Full Text] [Related]
7. Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity.
Bhakta V; Gierczak RF; Sheffield WP
J Biotechnol; 2013 Dec; 168(4):373-81. PubMed ID: 24140600
[TBL] [Abstract][Full Text] [Related]
8. Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Sheffield WP; Eltringham-Smith LJ; Bhakta V; Gataiance S
Thromb Haemost; 2012 May; 107(5):972-84. PubMed ID: 22370677
[TBL] [Abstract][Full Text] [Related]
9. The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of alpha1-proteinase inhibitor M358R for thrombin.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Haemost; 2007 Nov; 98(5):1014-23. PubMed ID: 18000606
[TBL] [Abstract][Full Text] [Related]
10. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
[TBL] [Abstract][Full Text] [Related]
11. Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin.
Scott BM; Matochko WL; Gierczak RF; Bhakta V; Derda R; Sheffield WP
PLoS One; 2014; 9(1):e84491. PubMed ID: 24427287
[TBL] [Abstract][Full Text] [Related]
12. Retention of thrombin inhibitory activity by recombinant serpins expressed as integral membrane proteins tethered to the surface of mammalian cells.
Gierczak RF; Sutherland JS; Bhakta V; Toltl LJ; Liaw PC; Sheffield WP
J Thromb Haemost; 2011 Dec; 9(12):2424-35. PubMed ID: 21972922
[TBL] [Abstract][Full Text] [Related]
13. Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.
Hamada M; Bhakta V; Andres SN; Sheffield WP
Front Cardiovasc Med; 2021; 8():647405. PubMed ID: 33816577
[TBL] [Abstract][Full Text] [Related]
14. Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa.
Martínez-Martínez I; Ordóñez A; Pedersen S; de la Morena-Barrio ME; Navarro-Fernández J; Kristensen SR; Miñano A; Padilla J; Vicente V; Corral J
Thromb Res; 2011 Feb; 127(2):154-60. PubMed ID: 21126754
[TBL] [Abstract][Full Text] [Related]
15. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
Björquist P; Boström S
Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
[TBL] [Abstract][Full Text] [Related]
16. Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis.
Bhakta V; Hamada M; Nouanesengsy A; Lapierre J; Perruzza DL; Sheffield WP
Sci Rep; 2021 Mar; 11(1):5565. PubMed ID: 33692375
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.
Sen P; Komissarov AA; Florova G; Idell S; Pendurthi UR; Vijaya Mohan Rao L
J Thromb Haemost; 2011 Mar; 9(3):531-9. PubMed ID: 21143380
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
Lormeau JC; Herault JP; Herbert JM
Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
[TBL] [Abstract][Full Text] [Related]
19. LDL receptor-related protein 1 contributes to the clearance of the activated factor VII-antithrombin complex.
Fazavana JG; Muczynski V; Proulle V; Wohner N; Christophe OD; Lenting PJ; Denis CV
J Thromb Haemost; 2016 Dec; 14(12):2458-2470. PubMed ID: 27614059
[TBL] [Abstract][Full Text] [Related]
20. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]